Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lixte Biotech Hlds (LIXT)

Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,901
  • Shares Outstanding, K 5,704
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,590 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.84 +9.11%
on 11/06/25
4.97 -15.69%
on 11/13/25
-0.26 (-5.84%)
since 10/14/25
3-Month
3.08 +36.03%
on 08/22/25
6.26 -33.07%
on 09/12/25
+0.29 (+7.44%)
since 08/14/25
52-Week
0.64 +554.69%
on 06/18/25
6.26 -33.07%
on 09/12/25
+2.59 (+161.88%)
since 11/14/24

Most Recent Stories

More News
LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3

BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100,...

LIXT : 4.19 (-2.56%)
LIXTW : 0.0851 (-40.90%)
LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

Company underscores clinical execution and confirms advanced negotiations  underway on acquisition of complementary oncology assets BOCA RATON, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LIXTE...

LIXT : 4.19 (-2.56%)
LIXTW : 0.0851 (-40.90%)
LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions

BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today...

LIXT : 4.19 (-2.56%)
LIXTW : 0.0851 (-40.90%)
24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor

Unlocking a New Era in Cancer TreatmentDenver, Colorado--(Newsfile Corp. - September 5, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news...

LIXT : 4.19 (-2.56%)
LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer

-- Company Relocates Corporate Headquarters to Boca Raton -- Boca Raton, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) (Nasdaq:...

LIXT : 4.19 (-2.56%)
LIXTW : 0.0851 (-40.90%)
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy

DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication...

LIXT : 4.19 (-2.56%)
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology...

LIXT : 4.19 (-2.56%)
24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100

DENVER, Aug. 19, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits the LIXTE...

LIXT : 4.19 (-2.56%)
LIXTE Biotechnology Holdings Provides Corporate Update

-Completes Two Financings, Raising $6.5 Million- -Regains Compliance for Continued Listing on Nasdaq- -Announces Management Changes; Adds Two New Board Members- -Re-Establishes Scientific...

LIXT : 4.19 (-2.56%)
LIXTW : 0.0851 (-40.90%)
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information...

LIXT : 4.19 (-2.56%)

Business Summary

Lixte Biotechnology Holdings Inc. is a drug discovery company which uses biomarker technology to identify enzyme targets associated with serious common diseases. The company's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents...

See More

Key Turning Points

3rd Resistance Point 4.51
2nd Resistance Point 4.40
1st Resistance Point 4.29
Last Price 4.19
1st Support Level 4.07
2nd Support Level 3.96
3rd Support Level 3.85

See More

52-Week High 6.26
Last Price 4.19
Fibonacci 61.8% 4.11
Fibonacci 50% 3.45
Fibonacci 38.2% 2.79
52-Week Low 0.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar